Pharmaceutical Spending Continues Steady
Increase
By Ceci
Connolly
For the fourth straight year,
prescription drug spending rose more than 17 percent in 2001, driven in
large measure by a few heavily advertised, high-priced medications, a
nonpartisan study released yesterday found.
Sales of prescription
medication at retail stores and through mail-order companies totaled
$175.2 billion last year, an
increase of $27 billion over 2000, according to the National Institute for
Health Care Management. The institute is a private, nonprofit research
organization led by physicians, insurance executives and policymakers from
both parties.
Overall, pharmaceutical costs
continue to be the fastest-rising component of health care expenditures,
accounting for about 10 percent of spending. Although price increases were
part of the reason for the jump, the researchers found that drug use and
advertising were also prime factors. In short, more doctors are writing more
prescriptions for the most expensive, heavily marketed drugs.
While the trend was criticized
by some consumer advocates and politicians, pharmaceutical makers and some
economists said today's blockbuster drugs save not only lives, but also
dollars.
"Although
we talk about how fast drug costs are going up, this is helping to reduce
the rate of growth of other medical costs," said Frank Lichtenberg, an
economist at Columbia University's business school.
In a number of studies,
Lichtenberg has found that modern medications help people live longer, with
a better quality of life, so they spend less time in hospitals and more time
contributing to society.
"Ultimately, they provide
tremendous benefits to society," he said.
Nevertheless, he said there is
plenty of waste in the pharmaceutical industry and "ridiculous" decisions by
doctors and patients about which medication to use when. Take the people who
insist upon eating fatty foods late at night and never exercise, he said.
"They don't want to lose weight
or change their diet or take Tums. They're pummeled by advertising, so they
go to the doctor demanding" a prescription medication such as Prilosec or
Prevacid, he said. "That's a waste."
Frank Clemente, director of
Public Citizen's Congress Watch, said few doubt the value of the latest
medical advances, but he believes it appears the industry is price-gouging.
"The prices are greatly in excess of what they need to have research and
development dollars,"
he said. On average over the past decade, the pharmaceutical industry has
been the most profitable by far, he said, reporting profits about three
times the size of other Fortune 500 industries.
With so much money at stake,
both sides have invested heavily in shaping public opinion.
The National Institute for
Health Care Management, the author of the report, receives funding from the
federal government and insurers. Researchers such as Lichtenberg and
Vermeulen said they are subsidized by drug manufacturers.
Last year, about three dozen
drugs were responsible for half the total increase in expenditures,
according to yesterday's study.
Americans consumed record
quantities of well-known drugs such as Prozac, Lipitor and Prilosec to treat
depression, high cholesterol and heartburn, respectively.
Antidepressants remain the top-selling therapeutic class, with $12.5 billion
in retail sales.
The average price for a
prescription rose 10 percent, from $45.27 to $49.84, the study found. The
average price among the 50 best-selling drugs was $71.56.
In many categories, two or
three medications dominated the market. Nearly 75 percent of the
prescriptions written to treat heartburn were for Prilosec or Prevacid, for
instance.
Washington Post March 29, 2002; Page A09
DR. MERCOLA'S COMMENT:
It is a sad but not
unexpected tragedy that our drug use is being extended to children.
Americans had more than 3 billion prescriptions
filled
last year.
On the average that is one
prescription for every man woman and children in the US every single month.
Like the late Senator
Everett Dirksen from Illinois was fond of saying when he was referring to
the Defense Department budget, a billion dollars here, a billion dollars
there and before you know it you are talking real money.
Retail pharmacies filled 3 billion prescriptions in 2000.
Well we are talking a lot
more than a few billion dollars. How about something like a nearly 200
billion dollars for drugs spent last year.
The sad tragedy is that we
are spending all of this money on disease management focused on drugs and
our return on this investment is profoundly poor.
Clearly there is something
seriously wrong here.
Related Articles:
Health
Spending Growing Faster Than US Economy
Return to Table of Contents #315 |